Prestige Consumer Healthcare (PBH) stock experienced a significant pre-market plunge of 6.79% on Thursday. The sharp decline occurred during the pre-market trading session, reflecting heightened investor concern.

The movement appears to be primarily driven by Oppenheimer's decision to downgrade Prestige Consumer Healthcare from "Outperform" to "Perform." This rating adjustment by a major financial firm typically signals reduced confidence in the stock's near-term prospects and can trigger immediate selling pressure.

Additional context for the negative sentiment may stem from the company's recent financial performance. Prestige Consumer Healthcare previously reported quarterly results that missed analyst expectations for both revenue and earnings per share, coupled with issuing guidance for the coming fiscal year that fell below market projections.